Therapeutic Potential of „Derived-Multiple Allogeneic Proteins Paracrine Signaling-D-Mapps” in the Treatment of Dry Eye Disease
Authors
Carl Randall Harrell
Regenerative Processing Plant, LLC, Palm Harbor, Florida, United States of America
Crissy Fellabaum
Regenerative Processing Plant, LLC, Palm Harbor, Florida, United States of America
Dragica Miloradovic
University of Kragujevac, Faculty of Medical Sciences, Department of Microbiology and Immunology, Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
Aleksandar Acovic
University of Kragujevac, Faculty of Medical Sciences, Department of Dentistry, Kragujevac, Serbia
Dragana Miloradovic
University of Kragujevac, Faculty of Medical Sciences, Department of Genetics, Kragujevac, Serbia
Bojana Simovic Markovic
University of Kragujevac, Faculty of Medical Sciences, Department of Microbiology and Immunology, Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
Nebojsa Arsenijevic
University of Kragujevac, Faculty of Medical Sciences, Department of Microbiology and Immunology, Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
Paul Karpecki
Optometrist in Private Practice, United States of America
Vladislav Volarevic
University of Kragujevac, Faculty of Medical Sciences, Department of Microbiology and Immunology, Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
Language: English
Page range: 167 - 173
Submitted on: Sep 17, 2019
Accepted on: Dec 1, 2019
Published on: Jul 11, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2022 Carl Randall Harrell, Crissy Fellabaum, Dragica Miloradovic, Aleksandar Acovic, Dragana Miloradovic, Bojana Simovic Markovic, Nebojsa Arsenijevic, Paul Karpecki, Vladislav Volarevic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.